Case Investigations

Snap, Inc.

January 16, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Snap, Inc. (“Snap” or the “Company”) (NYSE: SNAP).  Investors who purchased Snap common stock between March 2, 2017 and August 10, 2017, inclusive (the “Class Period”) may be affected.

GreenSky, Inc.

January 15, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of GreenSky, Inc. (“GreenSky” or the “Company”) (NASDAQ: GSKY).  GreenSky is a financial technology company that runs an online platform for processing loan applications at the point of sale.

AxoGen, Inc.

January 11, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of AxoGen, Inc. (“AxoGen” or the “Company”) (NASDAQ: AXGN), a company that purports to provide surgical solutions for physical damage or discontinuity to peripheral nerves.  AxoGen’s products include nerve allografts and extracellular matrices.  Investors who purchased AxoGen securities between August 7, 2017 and December 18, 2018, inclusive (the “Class Period”) may be affected.

Alkermes plc

January 8, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Alkermes plc (“Alkermes” or the “Company”) (NASDAQ: ALKS).  Investors who purchased Alkermes securities between February 17, 2017 and November 1, 2018, inclusive (the “Class Period”) may be affected.  A complaint has been filed in the United States District Court for the Eastern District of New York against Alkermes, the Company’s Chairman and CEO, and its CFO on behalf of investors of Alkermes securities during the Class Period.

Immunomedics Inc.

January 8, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Immunomedics, Inc. (“Immunomedics” or the “Company”) (NASDAQ: IMMU).  Investors who purchased Immunomedics common stock between August 23, 2018 and December 20, 2018, inclusive (the “Class Period”) may be affected.  A complaint has been filed in the United States District Court for the District of New Jersey against Immunomedics, the Company’s President and CEO, and its CFO on behalf of investors in Immunomedics common stock during the Class Period.

DXC Technology Company

January 8, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of DXC Technology Company (“DXC Technology” or the “Company”) (NYSE: DXC).  Investors who purchased DXC Technology common stock between February 8, 2018 and November 6, 2018, inclusive (the “Class Period”) may be affected.  A complaint has been filed in the United States District Court for the Eastern District of Virginia against DXC Technology,  J. Michael Lawrie, the Company’s CEO, and Paul N. Saleh, the Company’s CFO, on behalf of investors in DXC Technology common stock during the Class Period.

Perrigo Company plc

January 2, 2019 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased Perrigo Company plc (“Perrigo”) (NYSE: PRGO) securities.  Perrigo is a global healthcare company that is headquartered in Ireland, and sells its products primarily in North America and Europe, as well as in other markets, including Australia, Israel and China.

Nobilis Health Corp.

December 17, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased Nobilis Health Corp. (“Nobilis”) (NYSE American: HLTH) securities between May 8, 2018 and November 15, 2018 (the “Class Period”).  A complaint has been filed in the United States District Court for the Southern District of Texas against Nobilis, the Company’s CEO, and its former and current CFOs on behalf of investors of Nobilis securities during the Class Period.

Belden Inc.

December 13, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased Belden Inc. securities (“Belden” or the “Company”) (NYSE: BDC).

Cheetah Mobile Inc.

December 7, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Cheetah Mobile Inc. (“Cheetah” or the “Company”) (NYSE: CMCM).  Investors who purchased Cheetah securities between April 26, 2017 and November 27, 2018 (the “Class Period”) may be affected.  A complaint has been filed in the United States District Court for the Southern District of New York against Cheetah, the Company’s CEO, and its CFO on behalf of investors of Cheetah securities during the Class Period.

Evoqua Water Technologies Corp.

December 4, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Evoqua Water Technologies Corp. (“Evoqua” or the “Company”) (NYSE: AQUA).  Investors who purchased Evoqua securities between November 6, 2017 and October 30, 2018 (the “Class Period”) may be affected.  A complaint has been filed in the United States District Court for the Southern District of New York against Evoqua, the Company’s CEO, and its CFO on behalf of investors of Evoqua securities during the Class Period.

Aphria Inc.

December 4, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Aphria Inc. (“Aphria” or the “Company”) (NYSE: APHA) concerning potential securities law violations.  Investors who purchased Aphria securities may be affected.

Marriott International, Inc.

November 30, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Marriott International, Inc. (“Marriott” or the “Company”) (NASDAQ: MAR) concerning potential securities law violations.  Investors who purchased Marriott securities may be affected.

Goldman Sachs Group, Inc.

November 14, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Goldman Sachs Group, Inc. (“Goldman Sachs” or the “Company”) (NYSE: GS) concerning potential securities law violations.  Investors who purchased Goldman Sachs securities may be affected.

MoneyGram International, Inc.

November 9, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of MoneyGram International, Inc. (“MoneyGram” or the “Company”) (NASDAQ: MGI) concerning potential securities law violations.  Investors who purchased MoneyGram securities may be affected.

Yelp, Inc.

November 9, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims on behalf of investors of Yelp Inc. (“Yelp” or the “Company”) (NYSE: YELP).

Stitch Fix, Inc.

November 8, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Stitch Fix, Inc. (“Stitch Fix” or the “Company”) (NASDAQ: SFIX).  Investors who purchased Stitch Fix common stock between June 8, 2018 and October 1, 2018 (the “Class Period”) may be affected.  A complaint has been filed in the United States District Court for the Northern District of California against Stitch Fix and certain executives on behalf of investors of Stitch Fix common stock during the Class Period.

NiSource, Inc.

November 8, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of NiSource Inc. (“NiSource” or the “Company”) (NYSE: NI) concerning potential securities law violations.  Investors who purchased NiSource securities may be affected.

Bank OZK

November 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Bank OZK (“Bank OZK” or the “Company”) (NASDAQ: OZK).  Investors who purchased Bank OZK securities between February 19, 2016 and October 18, 2018 (the “Class Period”) may be affected.  A complaint has been filed in the United States District Court for the Eastern District of Arkansas against Bank OZK and certain former or current executives on behalf of investors that purchased or otherwise acquired Bank OZK securities during the Class Period.

Trevena, Inc.

November 2, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Trevena Inc. (“Trevena” or the “Company”) (NASDAQ: TRVN).  Investors who purchased Trevena securities between May 2, 2016 and October 9, 2018 (the “Class Period”) may be affected.  A complaint has been filed in the United States District Court for the Eastern District of Pennsylvania against Trevena and certain executives on behalf of investors that purchased or otherwise acquired Trevena securities during the Class Period.

Super Micro Computer, Inc.

October 4, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Super Micro Computer, Inc. (“Super Micro” or the “Company”) (OTC: SMCI) concerning potential securities law violations.  Investors who purchased Super Micro securities may be affected.

 

Geron Corporation

September 27, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of Menlo park, California-based Geron Corporation (“Geron” or the “Company”) (Nasdaq: GERN).

Chegg, Inc.

September 26, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of Santa Clara, California-based Chegg, Inc. (“Chegg” or the “Company”) (NYSE: CHGG).

Microchip Technology, Inc.

September 20, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Microchip Technology Inc. (“Microchip” or the “Company”) (NASDAQ: MCHP).  Investors who purchased Microchip common stock between March 2, 2018 and August 9, 2018 (the “Class Period”) may be affected.  A complaint has been filed in the United States District Court for the District of Arizona against Microchip and certain executives on behalf of investors that acquired Microchip common stock during the Class Period.

Pretium Resources, Inc.

September 18, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Pretium Resources, Inc. (“Pretium” or the “Company”) (NYSE: PVG).  Investors who purchased Pretium securities between July 21, 2016 and September 6, 2018 (the “Class Period”) may be affected.  A complaint has been filed in the United States District Court for the Southern District of New York against Pretium and certain executives on behalf of investors that acquired Pretium securities during the Class Period.

Qurate Retail, Inc.

September 18, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Qurate Retail, Inc. (“Qurate” or the “Company”) (NASDAQ: QRTEA).  Investors who purchased Qurate securities between August 5, 2015 and September 7, 2016 (the “Class Period”) may be affected.  A complaint has been filed in the United States District Court for the District of Colorado against Qurate and certain executives on behalf of investors that acquired Qurate securities during the Class Period.

AbbVie, Inc.

September 18, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of AbbVie Inc. (“AbbVie” or the “Company”).

OPKO Health, Inc.

September 11, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of OPKO Health, Inc. (“OPKO” or the “Company”) (Nasdaq: OPK).

USA Technologies, Inc.

September 11, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of USA Technologies, Inc. (“USA Technologies” or the “Company”), which is based in Malverne, Pennsylvania (Nasdaq: USAT).

Danske Bank A/S

September 11, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of Danske Bank A/S American Depository Shares (“Danske” or the “Company”) (OTC: DNKEY) (CUSIP: 236363206).